R.PR
REGISTERED-PRINCIPAL REGISTER
11/30/2021
Back to search
Official data from USPTO
SINTBILO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
11/30/2021
Trademark type
Combined
Nice classes
5
Filing date
09/04/2020
Registration date
11/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/30/2021
Last transaction
11/30/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
Suzhou City, CN
Examiner
WHITE, TRAVIS WILLIAM
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a circle from which thirteen rounded shapes protrude, two such shapes appearing to drift off to the left, with one small circle appearing above and to the left of the larger circle, with the word "SINTBILO" appearing to the right.
Holders and representatives
Holders
Innovent Biologics (Suzhou) Co., Ltd.
Representatives
Anessa Owen Kramer HONIGMAN LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; vaccines; drugs in the nature of pharmaceutical preparations for medical purposesused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; biological preparations for medical purposesused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; medicines for human purposesused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; pharmaceuticals contained in syringe for treating cancer or tumor; chemical preparations for medical purposespreparations used for treating tumorophthalmology diseasescardiovascular diseases immune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasesantivirals; dietetic foods adapted for medical use; biological preparations for veterinary purposes for the treatment of tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancer and antivirals; diagnostic preparations for medical purposes
Publications
History of USPTO decisions and trademark events.
20 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/14/2021
PUBO
PUBLISHED FOR OPPOSITION
09/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
08/06/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/06/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
08/06/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2021
ALIE
ASSIGNED TO LIE
07/23/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/20/2021
GNRT
NON-FINAL ACTION E-MAILED
01/20/2021
CNRT
NON-FINAL ACTION WRITTEN
01/20/2021
DOCK
ASSIGNED TO EXAMINER
01/12/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/09/2020
NWAP
NEW APPLICATION ENTERED
09/08/2020
Continuous trademark protection
Get notified about every new filing that threatens SINTBILO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.